RE:RE:RE:RE:Hint at New Product AcquisitionI just checked the 2002 to 2006 financials. No R&D expense. There are references to patents, trademarks and deferred development costs in cash flow statements and notes to the financials, but these relate to non-pharma assets.
Soooo, I'm wondering how you seem so confident that the company developed FeraMAX.